Loading...
Thalidomide and irradiation combination therapy increases substance P levels in vitro
Thalidomide is an anti-angiogenic agent that is used in the treatment of cancer. However, in many cases, particularly in patients with breast cancer, thalidomide treatment alone is insufficient and must be combined with other drugs or therapies. In the clinical setting, thalidomide is most commonly...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3440713/ https://ncbi.nlm.nih.gov/pubmed/22977536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.216 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|